title: The Revised International Prognostic Scoring System (IPSS-R) is not predictive of survival in patients with secondary myelodysplastic syndromes.
authors.affiliation: a Leukemia Program, Department of Hematology and Medical Oncology , Cleveland , OH , USA.
authors.forename: Aziz
authors.initials: A
authors.lastname: Nazha
authors.affiliation: a Leukemia Program, Department of Hematology and Medical Oncology , Cleveland , OH , USA.
authors.forename: David P
authors.initials: DP
authors.lastname: Seastone
authors.affiliation: a Leukemia Program, Department of Hematology and Medical Oncology , Cleveland , OH , USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Keng
authors.affiliation: a Leukemia Program, Department of Hematology and Medical Oncology , Cleveland , OH , USA.
authors.forename: Sean
authors.initials: S
authors.lastname: Hobson
authors.affiliation: a Leukemia Program, Department of Hematology and Medical Oncology , Cleveland , OH , USA.
authors.forename: Matt
authors.initials: M
authors.lastname: Kalaycio
authors.affiliation: b Department of Translational Hematology and Oncology Research , Cleveland Clinic, Taussig Cancer Institute , Cleveland , OH , USA.
authors.forename: Jaroslaw P
authors.initials: JP
authors.lastname: Maciejewski
authors.affiliation: a Leukemia Program, Department of Hematology and Medical Oncology , Cleveland , OH , USA.
authors.forename: Mikkael A
authors.initials: MA
authors.lastname: Sekeres
mesh_terms: D006801:Humans; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000401:mortality*; D011379:Prognosis